Page last updated: 2024-09-02

perindopril and Cell Transformation, Neoplastic

perindopril has been researched along with Cell Transformation, Neoplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ikenaka, Y; Kuriyama, S; Noguchi, R; Yoshii, J; Yoshiji, H	1

Other Studies

1 other study(ies) available for perindopril and Cell Transformation, Neoplastic

Article	Year
Combination of interferon and angiotensin-converting enzyme inhibitor, perindopril, suppresses liver carcinogenesis and angiogenesis in mice. Oncology reports, 2005, Volume: 13, Issue:3 Topics: Angiogenesis Inhibitors; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Chemoprevention; Drug Therapy, Combination; Interferon-beta; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Perindopril	2005

Article

Year

Combination of interferon and angiotensin-converting enzyme inhibitor, perindopril, suppresses liver carcinogenesis and angiogenesis in mice.

Oncology reports, 2005, Volume: 13, Issue:3

Topics: Angiogenesis Inhibitors; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Chemoprevention; Drug Therapy, Combination; Interferon-beta; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Perindopril

2005